The strategic Chinese move is aimed at hurting Trump’s Republican base since South Carolina is a Republican controlled state. The move also carefully targets U.S. jobs as well as hangs the carrot of potential auto exports from the U.S. to… Read More ›
Sanofi’s strength in molecular oncology is likely to provide it a competitive edge over its peers as to what drives the growth of cancer tissues, how these cells functions and proliferation in the body. In a strategic development, French drugmaker,… Read More ›
By targeting U.S. crude, Beijing has placed the Trump administration’s “energy dominance” in its cross-hairs. In a development that adds to pressure on the U.S. government to scale back trade pressures on China, energy analysts and executives have disclosed the… Read More ›
The shifting sands of the Dow are testament to the companies that were once perceived as unassailable household names before falling victims to an evolving economy. An original member of the S&P Dow Jones Indices, General Electric Co has lost… Read More ›
India is taking fast steps to get back at the United States on trade tariffs. According to a revised World Trade Organization filing by the country, it has proposed enhancing of tariffs on 30 US goods that are imported into… Read More ›
As the Greek government prepares to close its third bailout program, there is anticipated row between Eurozone finance ministers and the Greek government over the terms of a “golden goodbye”. One of the major issues that is likely to surface… Read More ›
Although previous protectionist efforts by the U.S. have weakened the dollar, Trump’s trade war rhetorics have, contrary to expectations, strengthened the dollar against a basket of major currencies. With U.S. President Donald Trump threatening to impose 10% tariffs on $200… Read More ›
The strategic move will enable Roche Holding AG to add Foundation Medicine’s portfolio of drugs to its basket of cancer treatments. FMI’s molecular insights will also enable Roche to create and develop new cancer treatments. On Tuesday, Swiss drugmaker Roche… Read More ›
The unexpected move was explained to be part of a package of measures to counteract a potential fallout from the trade conflict. On Tuesday, China’s central bank, the People’s Bank of China (PBOC), lent $31 billion (200 billion) to financial… Read More ›
With the U.S. Senate’s passing the amended annual National Defense Authorization Act, ZTE Corp has once again been drawn into the center of a trade skirmish that is gradually snowballing into a trade war. For ZTE, this is a time… Read More ›
manageria.biz 